Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
MultiVir, Inc.
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Amgen
University of Arizona
Columbia University
Astellas Pharma Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Northside Hospital, Inc.
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center